Filing Details
- Accession Number:
- 0001232524-18-000105
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-16 16:54:20
- Reporting Period:
- 2018-05-14
- Accepted Time:
- 2018-05-16 16:54:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1232524 | Jazz Pharmaceuticals Plc | JAZZ | Pharmaceutical Preparations (2834) | 981032470 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1601583 | P. Matthew Young | 5Th Fl, Waterloo Exchange Waterloo Rd Dublin 4 L2 | Evp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2018-05-14 | 842 | $166.00 | 37,623 | No | 4 | F | Direct | |
Ordinary Shares | Disposition | 2018-05-15 | 1,420 | $164.64 | 36,203 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | S | Direct |
Footnotes
- Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.